28 Jan 2026
Turning point
The company reports 21 trial participants worldwide
Neuralink's two-year update reported 21 participants enrolled in trials worldwide and described experience with digital control and assistive devices. These were sponsor-reported observations, not a conclusion that the technology was proven safe or effective for general use.
Sources and context
An attributed statement records what the speaker said.
- Two years of TelepathyCompany statement · Neuralink